MRI-Guided radiation boost shows promise in head and neck cancer trial
NCT ID NCT06880289
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving an extra dose of radiation to oxygen-poor (hypoxic) areas of head and neck tumors can improve treatment response. About 91 adults with advanced squamous cell cancer of the throat or voice box will receive standard chemo-radiation with or without the MRI-guided boost. The goal is to see if the boost leads to complete tumor disappearance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"Regina Elena" National Cancer Institute
Rome, Rome, 00144, Italy
-
IRCSS Regina Elena
Roma, Roma, 00144, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new drug boost the power of chemoradiation against head and neck cancer?
- Experimental antibody combo aims to boost immune attack on head and neck tumors
- Mouth rinse could ease painful radiation side effects for head and neck cancer patients
- Scientists hunt for blood markers to unmask hidden aggressive tumors
- New drug aims to spare cancer patients from debilitating mouth sores